Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.



  Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class
  Action Lawsuit Against AVEO Pharmaceuticals, Inc.

Business Wire

LOS ANGELES -- June 24, 2013

The Law Offices of Todd M. Garber announces that investors of AVEO
Pharmaceuticals, Inc. (“AVEO” or the “Company”) (NASDAQ: AVEO) have until July
8, 2013 to move for lead plaintiff status in the shareholder lawsuit filed in
the United States District Court for the District of Massachusetts. The
lawsuit was filed on behalf of a class (the “Class”) comprising all purchasers
of AVEO securities between January 3, 2012 and May 1, 2013 (the “Class
Period”).

AVEO engages in discovering, developing, and commercializing targeted cancer
therapies. The Complaint alleges that defendants issued materially false and
misleading statements throughout the Class Period regarding the Phase III
trial design and results for the Company’s drug Tivopath, or tivozanib, for
the treatment of advanced kidney cancer. Specifically, defendants
misrepresented or failed to disclose: (1) that the FDA had recommended that
the Company conduct an additional Phase III trial due to adverse trends in the
Company’s first Phase III trial; (2) the 25% higher rate of death associated
with tivozanib therapy compared to the control drug, sorafenib; (3) that
almost 90% of the patients studied in TIVO-1 were enrolled from sites in
Central and Eastern Europe with inconsistent treatment patterns from those in
the U.S.; and (4) as a result of the foregoing, the Company’s statements were
materially false and misleading at all relevant times.

If you are a member of the above-described Class, you may move the Court no
later than July 8, 2013 to serve as lead plaintiff; however, you must meet
certain legal requirements. To be a member of the Class you need not take any
action at this time. You may retain counsel of your choice or take no action
and remain an absent Class member. If you purchased AVEO shares prior to the
Class Period, or have any questions concerning this Notice or your rights or
interests with respect to these matters, please contact Todd M. Garber,
Esquire, of the Law Offices of Todd M. Garber, by telephone at 213-700-7262 or
by email to info@toddgarberlaw.com.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

Contact:

Law Offices of Todd M. Garber
Todd M. Garber, Attorney at Law
Los Angeles, California
213-700-7262
info@toddgarberlaw.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement